• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Ethyl 4-fluoro-2-hydroxybenzoate (CAS No. 1737-21-9): A Comprehensive Overview

Ethyl 4-fluoro-2-hydroxybenzoate, identified by its Chemical Abstracts Service (CAS) number CAS No. 1737-21-9, is a significant compound in the realm of organic chemistry and pharmaceutical research. This ester derivative of fluoro-substituted hydroxybenzoic acid has garnered attention due to its versatile applications and potential in drug development. The compound's unique structural features, characterized by a fluoro group at the para position relative to the hydroxyl group, contribute to its distinct chemical properties and reactivity, making it a valuable intermediate in synthetic chemistry.

The Ethyl 4-fluoro-2-hydroxybenzoate molecule exhibits notable solubility and stability, which are critical factors in pharmaceutical formulations. Its ability to undergo various chemical transformations, such as esterification and nucleophilic substitution, makes it a preferred building block for synthesizing more complex molecules. In recent years, the compound has been extensively studied for its role in developing novel therapeutic agents targeting a range of diseases.

One of the most compelling aspects of Ethyl 4-fluoro-2-hydroxybenzoate is its potential in medicinal chemistry. Researchers have explored its utility in creating bioactive molecules with anti-inflammatory, antimicrobial, and anticancer properties. The presence of the fluoro group enhances the metabolic stability and binding affinity of drug candidates, which is a crucial consideration in drug design. For instance, studies have demonstrated that fluoro-substituted compounds often exhibit improved pharmacokinetic profiles, leading to more effective therapeutic outcomes.

In the context of academic research, Ethyl 4-fluoro-2-hydroxybenzoate has been utilized in various synthetic protocols to develop novel heterocyclic compounds. These derivatives have shown promise in preclinical studies as potential treatments for neurological disorders, including Alzheimer's disease and Parkinson's disease. The hydroxyl and ester functionalities provide multiple sites for further chemical modification, allowing researchers to tailor the properties of the compound for specific biological targets.

The pharmaceutical industry has also recognized the significance of Ethyl 4-fluoro-2-hydroxybenzoate in drug discovery. Its incorporation into lead compounds has led to the development of several clinical candidates that are currently undergoing further investigation. The compound's ability to serve as a scaffold for structure-activity relationship (SAR) studies has been particularly valuable in optimizing drug candidates for better efficacy and reduced toxicity.

From an industrial perspective, the synthesis of Ethyl 4-fluoro-2-hydroxybenzoate involves well-established methodologies that ensure high yield and purity. Advanced catalytic techniques have been employed to enhance reaction efficiency and minimize byproduct formation. These advancements have not only improved the scalability of production but also reduced costs, making the compound more accessible for research and commercial applications.

The environmental impact of producing and utilizing Ethyl 4-fluoro-2-hydroxybenzoate is another area of interest. Efforts have been made to develop greener synthetic routes that reduce waste and energy consumption. These sustainable practices align with global initiatives to promote environmentally responsible chemical manufacturing, ensuring that the compound's benefits are realized without compromising ecological integrity.

In conclusion, Ethyl 4-fluoro-2-hydroxybenzoate (CAS No. 1737-21-9) represents a cornerstone in modern chemical research and pharmaceutical development. Its unique structural features and versatile reactivity make it an indispensable tool for scientists working on innovative therapeutics. As research continues to uncover new applications for this compound, its importance in advancing medical science is set to grow even further.

• 443-12-9(Ethyl 5-Fluoro-2-hydroxybenzoate)
• 392-04-1(Methyl 4-fluoro-2-hydroxybenzoate)
• 204707-42-6(Methyl 4-fluoro-2-methoxybenzoate)
• 391-92-4(Methyl 5-fluoro-2-hydroxybenzoate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)